(MedPage Today) — Cervical precancer rates dropped precipitously among young women who underwent screening after the human papillomavirus (HPV) vaccine was first recommended in the U.S., CDC researchers reported.
Among women ages 20 to 24 who…
Source link : https://www.medpagetoday.com/hematologyoncology/cervicalcancer/114412
Author :
Publish date : 2025-02-27 19:58:53
Copyright for syndicated content belongs to the linked Source.
